News
AgNovos Healthcare Completes Enrollment for CONFIRM Clinical Study
AgNovos Healthcare is pleased to announce the completion of enrollment for its CONFIRM clinical study.
Keep up to date on AgNovos events and related news
AgNovos and ESCEO support young investigators at the “BREAKFAST EVENT” on Saturday April 06, 2019 from 08.00 - 09.00
AgNovos Healthcare will participate in WCO in Paris from April 4th - 7th, 2019 exhibiting the CE-marked OSSURE LOEP kit and host the ESCEO – AGNOVOS YOUNG INVESTIGATOR AWARD “BREAKFAST EVENT”
AgNovos Healthcare is proud to partner again with ESCEO to provide grants to young investigators at the WCO in Paris.
Current pharmaceutical therapies can reduce hip fractures by up to 50%, but compliance to treatment is low and therapies take up to 18 months to reduce risk. Thus, alternative or complementary approaches to reduce the risk of hip fracture are needed.
AgNovos Healthcare will participate in the Osteologie Kongress in Frankfurt from March 28th - 30th .
Osteoporosis International recently published diagnosis and management guidance from ESCEO and IOF for postmenopausal women with osteoporosis. The publication marks the first time that Local Osteo-Enhancement Procedure has been recognized in this global treatment guidance document.